🔎 Trials Near Me

Početna › Ateroskleroza › Alabama

Kliničke studije za Ateroskleroza u državi Alabama

8 studija za Ateroskleroza traži sudionike na lokacijama u državi Alabama.

Gradovi u državi Alabama

Službeni tekst studije (engleski)

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Heart Center Research, LLC, Huntsville
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07783802

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

  • Birmingham Clinical Research, Birmingham
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 24. ruj 2026. · NCT07157774

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  • Alliance For Multispecialty Research - Daphne, Daphne
  • Eastern Shore Research Institute, Fairhope
  • Heart Center Research LLC, Huntsville
  • i još 2
U tijeku regrutacijaFaza 3
Od 45 do 99 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07037433

A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis

  • Heart Center Research, LLC, Huntsville
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07521007

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  • Nephrology of North Alabama, Decatur
  • Nephrology Consultants, LLC, Huntsville
  • DaVita Clinical Research Montgomery, Montgomery
U tijeku regrutacijaFaza 2/3
Od 18 godina i više · Oba spola · Ažurirano 21. ruj 2026. · NCT05485961

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

  • Research Site, Athens
  • Research Site, Birmingham
  • Research Site, Birmingham
  • i još 8
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 24. kol 2026. · NCT07000357

Pelacarsen Roll-over Extension Program

  • Parkway Medical Center, Birmingham
U tijeku regrutacijaFaza 3
Od 18 do 100 godina · Oba spola · Ažurirano 29. srp 2026. · NCT06875973

Polygenic Risk Score Implementation and Stratification for Managing Blood Pressure

  • University of Alabama at Birmingham, Birmingham
U tijeku regrutacija
Od 18 do 55 godina · Oba spola · Ažurirano 3. ruj 2025. · NCT06962488

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.